ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,910Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 200

$1.63M Total Retail Price of All Prescriptions

Rank: 4 out of 200

643 Patients Receiving at Least One Drug in Part D
88% Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Louisiana
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%. This is far more than peers.

Prescription Price

$102 was the average price of a prescription from this provider, compared to $115 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
NAMENDA 1,176 1,171* 166 1 25
FLUOXETINE HCL 1,044 979 214 2 13
CLONAZEPAM 1,035 808 202 B 3 2
EXELON 708 673 146 4 50
GABAPENTIN 566 490 103 5 30
DONEPEZIL HCL 510 493 101 6 33
PRAVASTATIN SODIUM 494 437 102 7 58
OLANZAPINE 382 352 82 A 8 10
LAMOTRIGINE 364 275 53 9 20
CYMBALTA 359 310 63 10 7
TRAZODONE HCL 337 228 55 11 3
CARBAMAZEPINE 333 243 63 12 46
MIRTAZAPINE 317 290 59 13 12
ABILIFY 296 225 47 A 14 14
QUETIAPINE FUMARATE 291 250 58 A 15 1
MISOPROSTOL 224 185 47 16 93
NAMENDA XR 211 206* 54 17 95
LEVOTHYROXINE SODIUM 207 149 54 18 42
AMLODIPINE BESYLATE 201 196* 48 19 48
ESCITALOPRAM OXALATE 200 174 31 20 11
NUEDEXTA 197 164 21 21 65
MEXILETINE HCL 179 154 42 10 22 100
PANTOPRAZOLE SODIUM 167 150 41 23 66
ROPINIROLE HCL 164 136 37 24 88
BUSPIRONE HCL 155 109 26 25 28
VENLAFAXINE HCL ER 138 104 19 26 15
LISINOPRIL 130 118 35 27 49
RIVASTIGMINE 127 127 17 28 97
OMEPRAZOLE 116 111* 31 29 41
DIVALPROEX SODIUM ER 116 82 25 29 8
TAMSULOSIN HCL 110 105* 24 31 82
DOXAZOSIN MESYLATE 109 104* 25 32 117
PAROXETINE HCL 105 105 15 33 29
METOPROLOL TARTRATE 103 81 22 34 63
SEROQUEL XR 102 66 18 A 35 27
RISPERIDONE 98 60 23 A 36 4
BUPROPION XL 96 82 17 37 19
LITHIUM CARBONATE 93 44 12 38 21
ESTRADIOL 88 70 20 R 39 121
GLYCOPYRROLATE 84 84 12 40 123
AMITRIPTYLINE HCL 83 57 19 R 41 40
DIVALPROEX SODIUM 82 50 14 42 23
PRISTIQ ER 82 56 16 42 43
LEVETIRACETAM 79 40 13 44 110
RAMIPRIL 79 <11 <11 44 124
TIAGABINE HCL 76 22 16 10 46 128
FUROSEMIDE 73 68* 29 47 59
LATUDA 71 66* 20 A 48 51
POTASSIUM CHLORIDE 67 62* 20 49 77
LORAZEPAM 67 62* 20 B 49 18
ZIPRASIDONE HCL 66 <11 <11 A 51 22
FANAPT 63 <11 <11 A 52 83
OXAZEPAM 63 58* 21 B 52 137
TOPIRAMATE 62 33 15 54 38
NEXIUM 61 <11 <11 55 98
CLOPIDOGREL 58 53* 17 56 108
NEUPRO 57 52* 20 57 141
CARBIDOPA-LEVODOPA-ENTACAPONE 56 <11 <11 58 142
DOXEPIN HCL 56 <11 <11 58 52
CARVEDILOL 55 55 12 60 115
GALANTAMINE HBR 54 <11 <11 61 118
ATENOLOL 53 41 11 62 91
AZILECT 50 <11 <11 63 152
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.